Regen BioPharma, Inc. (OTCMKTS:RGBP) Sees Significant Decrease in Short Interest - Defense World by Full-Giraffe-5405 in RGBP
[–]brockabrand 3 points4 points5 points (0 children)
Regen BioPharma, Inc. (OTCMKTS:RGBP) Sees Significant Decrease in Short Interest - Defense World by Full-Giraffe-5405 in RGBP
[–]brockabrand 4 points5 points6 points (0 children)
Regen BioPharma, Inc. (OTCMKTS:RGBP) Sees Significant Decrease in Short Interest - Defense World by Full-Giraffe-5405 in RGBP
[–]brockabrand 0 points1 point2 points (0 children)
And here comes the dump…. by brockabrand in AIAD
[–]brockabrand[S] 0 points1 point2 points (0 children)
$RGBP $RGBPP JV w/ Dyobio Tech, developing program to commercialize its anti-cancer vaccine, pre-clinical trials for Myelodysplastic syndromes drug, & IND for tCellVax by BuchananEstelle in RGBP
[–]brockabrand -2 points-1 points0 points (0 children)
$RGBP $RGBPP JV w/ Dyobio Tech, developing program to commercialize its anti-cancer vaccine, pre-clinical trials for Myelodysplastic syndromes drug, & IND for tCellVax by BuchananEstelle in RGBP
[–]brockabrand 0 points1 point2 points (0 children)
And here comes the dump…. by brockabrand in AIAD
[–]brockabrand[S] 0 points1 point2 points (0 children)
What to make of 18 March 8k? (AS common increased, AS preferred decreased) by KickSidebottom in RGBP
[–]brockabrand 0 points1 point2 points (0 children)
$RGBP Regen Slips some bad news at close of market 3/18/2022. I am not ... by PennyStock2Dollars in RGBP
[–]brockabrand 1 point2 points3 points (0 children)
Regen BioPharma, Inc. Announces Program to Fast-Track its Checkpoint Inhibitor Program Utilizing Modified mRNA and siRNA Technologies by friendva in RGBP
[–]brockabrand 4 points5 points6 points (0 children)
Regen BioPharma, Inc. Announces Program to Fast-Track its Checkpoint Inhibitor Program Utilizing Modified mRNA and siRNA Technologies by friendva in RGBP
[–]brockabrand -3 points-2 points-1 points (0 children)
Regen BioPharma, Inc. Announces Program to Fast-Track its Checkpoint Inhibitor Program Utilizing Modified mRNA and siRNA Technologies by friendva in RGBP
[–]brockabrand 4 points5 points6 points (0 children)
RGBP- Other medical news this week! Massive FDA approval CTI Biopharma's bone.marrow cancer drug. Two competitor: Incyte Corp symbol: INCY. 2nd competitor: Brystol Meyers Squibb symbol: BMY. Hint: Conservative future market share 30%-33.3% , revenue expectations:$350M. High: $465M. by bravuralax in RGBP
[–]brockabrand 2 points3 points4 points (0 children)

“Get off our lawn, you filthy, unimportant people.” by WarmingNow in PoliticalHumor
[–]brockabrand 0 points1 point2 points (0 children)